These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 2227413)

  • 1. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.
    Olsen HS; Cochrane AW; Dillon PJ; Nalin CM; Rosen CA
    Genes Dev; 1990 Aug; 4(8):1357-64. PubMed ID: 2227413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the caprine arthritis encephalitis virus (CAEV) rev N-terminal elements required for efficient interaction with the RRE.
    Abelson ML; Schoborg RV
    Virus Res; 2003 Mar; 92(1):23-35. PubMed ID: 12606073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA.
    Dillon PJ; Nelbock P; Perkins A; Rosen CA
    J Virol; 1990 Sep; 64(9):4428-37. PubMed ID: 2200888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element.
    Olsen HS; Beidas S; Dillon P; Rosen CA; Cochrane AW
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):558-67. PubMed ID: 2023097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B; Stutz F; Rosbash M
    J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.
    Mann DA; Mikaélian I; Zemmel RW; Green SM; Lowe AD; Kimura T; Singh M; Butler PJ; Gait MJ; Karn J
    J Mol Biol; 1994 Aug; 241(2):193-207. PubMed ID: 8057359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA.
    Benko DM; Robinson R; Solomin L; Mellini M; Felber BK; Pavlakis GN
    New Biol; 1990 Dec; 2(12):1111-22. PubMed ID: 2088501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary structure is the major determinant for interaction of HIV rev protein with RNA.
    Olsen HS; Nelbock P; Cochrane AW; Rosen CA
    Science; 1990 Feb; 247(4944):845-8. PubMed ID: 2406903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.
    Daly TJ; Rennert P; Lynch P; Barry JK; Dundas M; Rusche JR; Doten RC; Auer M; Farrington GK
    Biochemistry; 1993 Aug; 32(34):8945-54. PubMed ID: 8364040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
    Venkatesan S; Gerstberger SM; Park H; Holland SM; Nam Y
    J Virol; 1992 Dec; 66(12):7469-80. PubMed ID: 1433526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric inhibition of the HIV-1 Rev/RRE interaction by a 3'-methylphosphonate modified antisense oligo-2'-O-methylribonucleotide.
    Prater CE; Saleh AD; Wear MP; Miller PS
    Oligonucleotides; 2007; 17(3):275-90. PubMed ID: 17854268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.
    Malim MH; Cullen BR
    Cell; 1991 Apr; 65(2):241-8. PubMed ID: 2015625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein.
    Schoborg RV; Clements JE
    Virology; 1996 Dec; 226(1):113-21. PubMed ID: 8941328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE.
    Powell DM; Zhang MJ; Konings DA; Wingfield PT; Stahl SJ; Dayton ET; Dayton AI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):317-23. PubMed ID: 7552493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex.
    Böhnlein E; Berger J; Hauber J
    J Virol; 1991 Dec; 65(12):7051-5. PubMed ID: 1942257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.